Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Jack of All Trades who wrote (28431)	7/6/1998 11:06:00 AM
From: Big Dog	Read Replies (3) \| Respond to of 34592

CYGS in my opinion is just about ready to rocket out of here. It is going up quietly everyday and will continue to do so. This company, I am told is on the verge of a major announcement. I bought more today at 1.69 Monday July 6, 7:05 am Eastern Time Company Press Release CSI Researchers Express ssDNA in Vivo HOUSTON--(BW HealthWire)--July 6, 1998--Cryogenic Solutions Inc. (OTC BB:CYGS - news) announced the expression of sequence specific oligodeoxyribonucleotides from a ribonucleic acid expression vector. This in vivo expression of single-stranded DNA (ssDNA) that is complementary to an RNA template encoded in a vector was accomplished under a sponsored research agreement by CSI. The option of having flanking regions present or absent in the expressed ssDNA product is an additional useful property of this work. CSI holds the patent rights of this and related technology developed under the sponsored research agreement. This press release contains no forward looking statements and is therefore in no need of protection under the Securities Litigation Reform Act of 1995. Investment in the securities of the company is imprudent and not recommended if the press release as written is not clearly understood by the investor. Background information available on the website <www.biogenix.com> email -- cygs@wt.net For additional information please call 713/780-1399, 9-4 CST Investor relations -- Dell Gibson, VP Biotech details -- Craig Tomlinson, PhD -------------------------------------------------------------------------------- Contact: Cyrogenic Solutions Inc. Dell Gibson or Craig Tomlinson, 713/780-1399